Business Description
Redsense Medical AB
ISIN : SE0006965158
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.88 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 16.18 | |||||
Beneish M-Score | -2.32 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20 | |||||
3-Year EBITDA Growth Rate | 20.4 | |||||
3-Year EPS without NRI Growth Rate | 14.4 | |||||
3-Year FCF Growth Rate | 34.2 | |||||
3-Year Book Growth Rate | -31.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.06 | |||||
9-Day RSI | 50.71 | |||||
14-Day RSI | 51.73 | |||||
6-1 Month Momentum % | -13.73 | |||||
12-1 Month Momentum % | -4.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.35 | |||||
Quick Ratio | 4.28 | |||||
Cash Ratio | 3.3 | |||||
Days Inventory | 126.62 | |||||
Days Sales Outstanding | 66.38 | |||||
Days Payable | 86.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -14.39 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.91 | |||||
Operating Margin % | -26.55 | |||||
Net Margin % | -26.53 | |||||
FCF Margin % | -43.55 | |||||
ROE % | -23.63 | |||||
ROA % | -20.48 | |||||
ROIC % | -31.39 | |||||
3-Year ROIIC % | 39.45 | |||||
ROC (Joel Greenblatt) % | -150.7 | |||||
ROCE % | -21.54 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 72.8 | |||||
PS Ratio | 4.66 | |||||
PB Ratio | 3.42 | |||||
Price-to-Tangible-Book | 5.48 | |||||
EV-to-EBIT | -18.9 | |||||
EV-to-Forward-EBIT | -17.79 | |||||
EV-to-EBITDA | -19.13 | |||||
EV-to-Forward-EBITDA | -17.79 | |||||
EV-to-Revenue | 4.57 | |||||
EV-to-Forward-Revenue | 6.55 | |||||
EV-to-FCF | -10.66 | |||||
Price-to-Net-Current-Asset-Value | 5.57 | |||||
Price-to-Net-Cash | 10.56 | |||||
Earnings Yield (Greenblatt) % | -5.29 | |||||
FCF Yield % | -8.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Redsense Medical AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 23.515 | ||
EPS (TTM) (kr) | -2.208 | ||
Beta | 0 | ||
Volatility % | 54.03 | ||
14-Day RSI | 51.73 | ||
14-Day ATR (kr) | 0.421076 | ||
20-Day SMA (kr) | 7.172 | ||
12-1 Month Momentum % | -4.86 | ||
52-Week Range (kr) | 4.51 - 8.44 | ||
Shares Outstanding (Mil) | 16.44 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Redsense Medical AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Redsense Medical AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Redsense Medical AB Frequently Asked Questions
What is Redsense Medical AB(XSAT:REDS)'s stock price today?
When is next earnings date of Redsense Medical AB(XSAT:REDS)?
Does Redsense Medical AB(XSAT:REDS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |